183 related articles for article (PubMed ID: 21371136)
21. Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease: How Are They Changing in Response to Efforts to Control Them?
Snyder E; Credille B
Vet Clin North Am Food Anim Pract; 2020 Jul; 36(2):253-268. PubMed ID: 32327253
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
Sweeney MT; Brumbaugh GW; Watts JL
Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of susceptibility testing of Pasteurella multocida and Mannheimia haemolytica.
Catry B; Dewulf J; de Kruif A; Vanrobaeys M; Haesebrouck F; Decostere A
Microb Drug Resist; 2007; 13(3):204-11. PubMed ID: 17949308
[TBL] [Abstract][Full Text] [Related]
24. [Resistance pattern of bovine Pasteurella].
Hörmansdorfer S; Bauer J
Berl Munch Tierarztl Wochenschr; 1996 May; 109(5):168-71. PubMed ID: 8694744
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of florfenicol-resistant Pasteurella multocida isolates in Germany.
Kehrenberg C; Wallmann J; Schwarz S
J Antimicrob Chemother; 2008 Nov; 62(5):951-5. PubMed ID: 18786941
[TBL] [Abstract][Full Text] [Related]
26. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
Portis E; Lindeman C; Johansen L; Stoltman G
J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
[TBL] [Abstract][Full Text] [Related]
27. Bactericidal activity of tracheal antimicrobial peptide against respiratory pathogens of cattle.
Taha-Abdelaziz K; Perez-Casal J; Schott C; Hsiao J; Attah-Poku S; Slavić D; Caswell JL
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):289-94. PubMed ID: 23333196
[TBL] [Abstract][Full Text] [Related]
28. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
Stephens CP; Blackall PJ; Wade LK; Lowe LB
Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
[No Abstract] [Full Text] [Related]
29. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
30. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece.
Spiliopoulou I; Petinaki E; Papandreou P; Dimitracopoulos G
J Antimicrob Chemother; 2004 May; 53(5):814-7. PubMed ID: 15056638
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Potter T; Pelligand L; Toutain PL
J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
[TBL] [Abstract][Full Text] [Related]
32. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
Sweeney MT; Papich MG; Watts JL
J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
[TBL] [Abstract][Full Text] [Related]
33. [Resistance of bovine and porcine Pasteurella to florfenicol and other antibiotics].
Hörmansdorfer S; Bauer J
Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):422-6. PubMed ID: 9880937
[TBL] [Abstract][Full Text] [Related]
34. Isolation and antimicrobial susceptibilities of bacterial pathogens from bovine pneumonia: 1994--2002.
Welsh RD; Dye LB; Payton ME; Confer AW
J Vet Diagn Invest; 2004 Sep; 16(5):426-31. PubMed ID: 15460326
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory disease.
Kadlec K; Brenner Michael G; Sweeney MT; Brzuszkiewicz E; Liesegang H; Daniel R; Watts JL; Schwarz S
Antimicrob Agents Chemother; 2011 May; 55(5):2475-7. PubMed ID: 21402855
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of plasmids with antimicrobial resistant genes in avian isolates of Pasteurella multocida.
Wu JR; Shieh HK; Shien JH; Gong SR; Chang PC
Avian Dis; 2003; 47(4):1384-92. PubMed ID: 14708986
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a Pasteurella multocida plasmid and its use to express recombinant proteins in P. multocida.
Wright CL; Strugnell RA; Hodgson AL
Plasmid; 1997; 37(1):65-79. PubMed ID: 9073583
[TBL] [Abstract][Full Text] [Related]
38. Use of a polymerase chain reaction method to detect the leukotoxin gene lktA in biogroup and biovariant isolates of Pasteurella haemolytica and P trehalosi.
Fisher MA; Weiser GC; Hunter DL; Ward AC
Am J Vet Res; 1999 Nov; 60(11):1402-6. PubMed ID: 10566816
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium smegmatis Erm(38) is a reluctant dimethyltransferase.
Madsen CT; Jakobsen L; Douthwaite S
Antimicrob Agents Chemother; 2005 Sep; 49(9):3803-9. PubMed ID: 16127056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
